IntroductionHuman cytomegalovirus (CMV) is a widespread -herpes virus that infects more than half of the Western population. Primary infection induces a life-long latent infection in the immunocompetent host with asymptomatic episodes of viral replication, which are controlled by a vigorous immune response. CMV infection is responsible for increased morbidity and mortality after allogeneic stem cell transplantation (SCT) as either CMV reactivation in CMV-seropositive patients or primary infection in CMV-seronegative patients receiving grafts from seropositive donors. Several studies have demonstrated a significant decline in a overall survival in human leukocyte antigen-identical sibling transplantations or in unrelated transplantations where either the donor or the patient was CMV-seropositive. 1,2 The central mechanism controlling CMV infection is mediated by antigen-specific CD8 ϩ cytotoxic and CD4 ϩ ␣ T lymphocytes and natural killer (NK) cells. [3][4][5] CMV-specific CD3 ϩ CD8 ϩ CD28 Ϫ CD57 ϩ ␣ T cells are regarded as the principle effector cells controlling CMV reactivation. 6,7 Both humoral and cellular immunity is involved in protective immune responses to CMV reactivation and CMV resolution. 8 Recent interest has focused on ␥␦ T cells and their role in immune responses during CMV infection. ␥␦ T cells are often termed the "unconventional" T cells and represent a minor population of circulating T cells (Ͻ 5%) in humans but are present in large numbers in epithelial tissues. [9][10][11][12][13] In contrast to ␣ T cells, which recognize peptides bound to major histocompatibility complex (MHC) class I or class II molecules, most ␥␦ T cells lack surface expression of CD4 or CD8 and display a non-MHC-restricted recognition. 14,15 There are 2 major subsets of ␥␦ T cells present in human peripheral blood: a subset of ␥␦ T cells expressing a T-cell receptor (TCR) encoded by the V␦2 and V␥9 gene segments, which accounts for 50% to 90% of ␥␦ T cells in adult peripheral blood and a minor V␦1 subset more frequent at mucosal epithelium sites, such as skin and the intestine. An additional small subset of V␦3 ␥␦ T cells is also present in peripheral blood but represents a minor population of less than 0.1% of CD3 ϩ T cells. The ␥␦ T cells recognize ligands that are not seen by ␣ T cells and provide additional means by which the immune system can maintain local immunosurveillance with immediate tumor defense, selective recognition of viral antigens, and bacterial metabolites. 12,14 V␦1 ␥␦ T cells recognize ligands for an activating receptor NKG2D, such as MHC class I-related chain A (MICA and MICB) stress-induced antigens expressed on epithelial tumor cells, some leukemias, lymphomas, and the UL16-binding proteins. [16][17][18][19][20][21][22][23][24] V␦2 ␥␦ T cells recognize low molecular weight nonpeptidic phosphoantigens, particularly intermediates of the nonmevalonate pathway of bacterial isoprenoid biosynthesis 25 or isopenthenyl pyrophosphate and aminobiphosphonates in eukaryotic cells. 26 Recent studies have...